Mira Sharma

Mira Sharma is an experienced professional in the biotechnology and healthcare sectors, currently serving as the Equity Research Associate Director at Oppenheimer & Co. Inc. since March 2025, focusing on SMid-Cap Biotech. Prior to this role, Mira held the position of Strategy Associate at Vial from May 2024 to March 2025, where the emphasis was on Competitive Intelligence and Pipeline Innovation. Earlier experience includes serving as an Equity Research Senior Associate at Citi, specializing in MedTech, from September 2022 to December 2023. Mira also contributed to research as a Graduate and Undergraduate Student Researcher at NYU Langone Health from February 2018 to July 2022 and worked as a Graduate Teacher's Assistant at New York University, teaching courses in Bioinformatics in Medicine & Biology and Biostatistics with R Programming. Mira holds a Master's degree in Biology and a Bachelor's degree in Biology & Psychology from New York University, completed between 2020 and 2022 and 2016 and 2020, respectively, after attending American Heritage Schools - Palm Beach Campus from 2012 to 2016.